Tag: #Global Trends

Eli Lilly has issued an open letter warning of a potentially dangerous chemical impurity found in compounded versions of Tirzepatide... Read more

Following major outlays in China and the U.S., Eli Lilly has announced plans to boost capacity at its sole Japanese... Read more

Despite the rise of Tecvayli—a bispecific therapy from its partner Johnson & Johnson—Legend Biotech maintains confidence in its CAR-T therapy,... Read more

Swiss pharmaceutical giant Sandoz has announced the creation of a specialized unit for biosimilar development, manufacturing, and supply. This strategic... Read more

The FDA has formally issued a warning letter to Novo Nordisk following the discovery of "serious violations" regarding the investigation... Read more

The husband-and-wife duo who founded BioNTech, Uğur Şahin and Özlem Türeci, have announced their departure from top executive roles to... Read more

Biotech startup Vima Therapeutics has announced a $100 million Series A funding round to accelerate the clinical testing of a... Read more

Eli Lilly has announced a massive investment plan to establish a localized production and supply system in China, specifically targeting... Read more

Biotech giant Biogen has unveiled encouraging results from early-stage trials of salanersen, an experimental candidate designed to succeed its flagship... Read more